skip to Main Content

The continuing rise of biosimilars in the UK

The entrance of biosimilar competitors into a therapeutic area is an ever-present concern for pharmaceutical companies managing ageing product portfolios. On the other hand, any potential benefit to patients and…

Read More

UK government publishes new draft data strategy

The government has this week published the long-awaited draft data strategy: Data saves lives: reshaping health and social care with data. This new strategy builds upon previous attemptsto harness the NHS’s rich store of patient…

Read More

Femtech – the way forward for women?

At the beginning of April, many European nations halted their vaccination programme in fears that the Oxford-AstraZeneca Covid-19 vaccine increased the recipient’s chances of developing severe and deadly blood clots.…

Read More
Back To Top